Insider Transactions Reported by 19 Insiders of Athenex, Inc.

Location
Buffalo, NY

There are no Buy or Sell transactions made by insiders since 28 Jan 2025

Athenex, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JOHNSON YIU NAM LAU CEO and Chairman of the Board, Director $405,210 05 May 2023
JEFFREY YORDON COO, and President, Athenex Pharmaceutical Division. $334,482 03 Aug 2022
Manson Fok Director $203,972 21 Apr 2023
William Wei Zuo President, China Division $194,321 03 Aug 2021
Daniel Lang Pres Cell Therapy, VP Corp Dev $110,962 16 Sep 2022
Rudolf Kwan EVP, Chief Medical Officer $67,750 05 May 2023
JINN WU Director $47,331 21 Apr 2023
Jordan Kanfer Director $23,237 03 Aug 2022
Benson Kwan Hung TSANG Director $23,011 21 Apr 2023
JOHN VIERLING Director $16,767 21 Apr 2023
KIM CAMPBELL Director $13,600 03 Aug 2021
Stephanie A. Davis Director $10,900 21 Apr 2023
Simon Pedder Officer $7,222 03 Aug 2021
Michael Smolinski Chief Scientific Officer $7,035 16 Nov 2021
Robert J. Spiegel Director $6,245 21 Apr 2023
Timothy DeVere Cook Chief Business and Commercial Officer, Proprietary Drugs $5,630 05 May 2023
Joe Annoni Chief Financial Officer $510 22 Feb 2023
Steven J. Adams Interim Chief Acct Officer 03 Aug 2021
Teresa Bair General Counsel, SVP Admin. 03 Aug 2021

Recent Insider Transactions by Companies or Individuals for Athenex, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.